Transcriptomics

Dataset Information

0

MYBL2 Is a Sub-haploinsufficient Tumor Suppressor Gene in Myeloid Malignancy (RNA)


ABSTRACT: A dosage-dependent role for tumor suppressor genes in the initiation of myeloid malignancies remains controversial. Here we show that MYBL2 is expressed at sharply reduced levels in CD34+ cells from most patients with myelodysplastic syndrome (MDS; 65%; n=26). In a murine competitive reconstitution model, Mybl2 knockdown by RNAi to 20-30% of normal levels in multipotent hematopoietic progenitors led to clonal dominance by these “sub-haploinsufficient” cells, affecting all blood cell lineages. By 6 months post-transplantation, the reconstituted mice had developed a myeloproliferative/myelodysplastic disorder originating from the cells with aberrantly reduced Mybl2 expression. Thus, downregulation of MYBL2 activity to levels below those predicted by classical haploinsufficiency drives the clonal expansion of hematopoietic progenitors in a large fraction of human MDS cases.

ORGANISM(S): Homo sapiens

PROVIDER: GSE43399 | GEO | 2013/09/15

SECONDARY ACCESSION(S): PRJNA185830

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2013-09-15 | E-GEOD-43399 | biostudies-arrayexpress
2013-09-15 | E-GEOD-43400 | biostudies-arrayexpress
2013-09-15 | GSE43400 | GEO
2009-05-28 | GSE16236 | GEO
2009-05-28 | E-GEOD-16236 | biostudies-arrayexpress
2019-10-30 | PXD013609 | Pride
2009-12-23 | GSE19610 | GEO
2014-02-07 | E-GEOD-54737 | biostudies-arrayexpress
2011-08-13 | E-GEOD-30201 | biostudies-arrayexpress
2022-11-02 | GSE201271 | GEO